Literature DB >> 18451716

Pediatric headache.

Paul Winner1.   

Abstract

PURPOSE OF REVIEW: Headaches occur frequently in the pediatric population and have a significant impact on both the patient and their family. Migraine, the most common headache disorder for which patients see a physician, still remains underdiagnosed and undertreated. Recent studies have revealed the increasing incidence of migraine and chronic migraine in the pediatric population. RECENT
FINDINGS: Limitations of the present diagnostic criteria for migraine are presented, and the proposed modifications to these criteria may assist you with early recognition and ultimate treatment. New acute and preventive migraine treatment data demonstrating statistically significant benefit for the primary endpoints will be reviewed in detail. The clinically relevant impact of migraine on the pediatric patient documented by the use of the Pediatric Migraine Disability Assessment and the Pediatric Quality of Life Inventory will be discussed.
SUMMARY: A comprehensive management approach blending the most current acute, preventive, and biobehavioral treatments will be reviewed. Further research, with novel study designs, in pediatric headaches is needed to help reveal additional pathophysiological mechanisms, improve diagnostic criteria, and advance optimal treatment. Prospective studies are needed to fully evaluate the efficacy of preventive management in this population and to establish whether early intervention might slow this disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18451716     DOI: 10.1097/WCO.0b013e3282fe205b

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  8 in total

Review 1.  New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us?

Authors:  Joanne Kacperski; Allyson Bazarsky
Journal:  Curr Pain Headache Rep       Date:  2017-08

Review 2.  Preventive drugs in childhood and adolescent migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2014-06

Review 3.  Migraine treatment in developmental age: guidelines update.

Authors:  Laura Papetti; Alberto Spalice; Francesco Nicita; Maria Chiara Paolino; Rosa Castaldo; Paola Iannetti; Maria Pia Villa; Pasquale Parisi
Journal:  J Headache Pain       Date:  2010-03-27       Impact factor: 7.277

Review 4.  From 0° to 18°: how headache changes over time.

Authors:  Vincenzo Guidetti; Noemi Faedda
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 5.  The optimal management of headaches in children and adolescents.

Authors:  Joanne Kacperski; Marielle A Kabbouche; Hope L O'Brien; Jessica L Weberding
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

6.  Assessing evidence-based medicine and opioid/barbiturate as first-line acute treatment of pediatric migraine and primary headache: A retrospective observational study of health systems data.

Authors:  Elizabeth K Seng; Amy A Gelfand; Robert A Nicholson
Journal:  Cephalalgia       Date:  2019-02-20       Impact factor: 6.292

Review 7.  Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

8.  The clinical characteristics of primary headache and associated factors in children: A retrospective descriptive study.

Authors:  Miral Al Momani; Basima A Almomani; Amira T Masri
Journal:  Ann Med Surg (Lond)       Date:  2021-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.